Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niv Papo

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Biochemistry|May 26, 2004
Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptidesNiv Papo, Yechiel Shai
Biochemistry|August 6, 2003
New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cellsNiv Papo, Yechiel Shai
Peptides|March 17, 2004
Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?Niv Papo, Yechiel Shai
The Journal of Biological Chemistry|January 6, 2005
A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptidesNiv Papo, Yechiel Shai
Biochemistry|January 15, 2003
Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptidesNiv Papo, Yechiel Shai
Current Opinion in Structural Biology|March 19, 2017
Editorial overview: Engineering and design: New trends in designer proteinsJulia M Shifman, Niv Papo
The Biochemical Journal|February 18, 2021
Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategyGal Yosef, Hezi Hayun, Niv Papo
The Journal of Biological Chemistry|November 19, 2005
Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of actionYosef Rosenfeld, Niv Papo, Yechiel Shai
Cellular and Molecular Life Sciences : CMLS|October 13, 2021
Amyloid β structural polymorphism, associated toxicity and therapeutic strategiesOfek Oren, Ran Taube, Niv Papo
The Journal of Biological Chemistry|July 11, 2018
Targeting the MMP-14/MMP-2/integrin α<sub>v</sub>β<sub>3</sub> axis with multispecific N-TIMP2-based antagonists for cancer therapyGal Yosef, Valeria Arkadash, Niv Papo
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Biochemistry|May 26, 2004
Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptidesNiv Papo, Yechiel Shai
Biochemistry|August 6, 2003
New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cellsNiv Papo, Yechiel Shai
Peptides|March 17, 2004
Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?Niv Papo, Yechiel Shai
The Journal of Biological Chemistry|January 6, 2005
A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptidesNiv Papo, Yechiel Shai
Biochemistry|January 15, 2003
Exploring peptide membrane interaction using surface plasmon resonance: differentiation between pore formation versus membrane disruption by lytic peptidesNiv Papo, Yechiel Shai
Current Opinion in Structural Biology|March 19, 2017
Editorial overview: Engineering and design: New trends in designer proteinsJulia M Shifman, Niv Papo
The Biochemical Journal|February 18, 2021
Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategyGal Yosef, Hezi Hayun, Niv Papo
The Journal of Biological Chemistry|November 19, 2005
Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of actionYosef Rosenfeld, Niv Papo, Yechiel Shai
Cellular and Molecular Life Sciences : CMLS|October 13, 2021
Amyloid β structural polymorphism, associated toxicity and therapeutic strategiesOfek Oren, Ran Taube, Niv Papo
The Journal of Biological Chemistry|July 11, 2018
Targeting the MMP-14/MMP-2/integrin α<sub>v</sub>β<sub>3</sub> axis with multispecific N-TIMP2-based antagonists for cancer therapyGal Yosef, Valeria Arkadash, Niv Papo
Pageof 9